Navigation Links
New technique detects microscopic diabetes-related eye damage
Date:4/17/2014

BLOOMINGTON, Ind. -- Indiana University researchers have detected new early-warning signs of the potential loss of sight associated with diabetes. This discovery could have far-reaching implications for the diagnosis and treatment of diabetic retinopathy, potentially impacting the care of over 25 million Americans.

"We had not expected to see such striking changes to the retinas at such early stages," said Ann Elsner, professor and associate dean in the IU School of Optometry and lead author of the study. "We set out to study the early signs, in volunteer research subjects whose eyes were not thought to have very advanced disease. There was damage spread widely across the retina, including changes to blood vessels that were not thought to occur until the more advanced disease states."

These important early-warning signs were invisible to existing diagnostic techniques, requiring new technology based on adaptive optics. Stephen Burns, professor and associate dean at the IU School of Optometry, designed and built an instrument that used small mirrors with tiny moveable segments to reflect light into the eye to overcome the optical imperfections of each person's eye.

"It is shocking to see that there can be large areas of retina with insufficient blood circulation," he said. "The consequence for individual patients is that some have far more advanced damage to their retinas than others with the same duration of diabetes."

Because these changes had not been observable in prior studies, it is not known whether improved control of blood sugar or a change in medications might stop or even reverse the damage. Further research can help determine who has the most severe damage and whether the changes can be reversed.

The study, "In vivo adaptive optics microvascular imaging in diabetic patients without clinically severe diabetic retinopathy," was published in the journal Biomedical Optics Express. It is available at '/>"/>

Contact: Tracy James
traljame@iu.edu
812-855-0084
Indiana University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. New technique will accelerate genetic characterization of photosynthesis
2. New technique takes cues from astronomy and ophthalmology to sharpen microscope images
3. Researchers develop novel molecular blood group typing technique
4. New technique brings us closer to HIV and Hepatitis C vaccines
5. New technique sheds light on human neural networks
6. New technique for identifying gene-enhancers
7. Heat-based technique offers new way to measure microscopic particles
8. NIST microanalysis technique makes the most of small nanoparticle samples
9. New technique makes biogasoline from plant waste
10. Facelift complications eased with help of new 3-D imaging technique
11. New monitoring technique reveals endangered animals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New technique detects microscopic diabetes-related eye damage
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the ... 2015-2019" report to their offering. ... is the adoption of multimodal biometric systems. Multimodal ... an individual for verification and identification purposes. This ...
(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
(Date:12/10/2014)... 9, 2014  Valencell, a leader in performance biometric ... staggering demand from its licensees for highly accurate, clinically ... not solely coming from fitness and health sectors, but ... "A wearable is only as useful as the biometric ... ultimate driver in long-term mass consumer adoption of wearable ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... by researchers originally looking for biological pest controls, may ... other inflammatory diseases, say researchers at the University of ... disease expert "as the most important discovery in inflammation ... effects associated with the painkiller, Vioxx. , Lead author ...
... the molecular mechanisms underlying axon growth and synapse formation ... today in the open access journal Journal of Biology, ... proper locomotion . They show that UNC-69 interacts with ... in the trafficking of vesicles along axons - a ...
... effort was launched last week to develop and use ... avoid potential rice shortages, or even future famine. , ... approach since the early 1990s. But new knowledge generated ... researchers for the first time to discuss how they ...
Cached Biology News:Pest control research leads to pain control discovery 2Pest control research leads to pain control discovery 3Newly identified protein complex sheds light on axon growth mechanism 2A more powerful and efficient engine for rice: the C3-C4 challenge 2
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... Calif. , Dec. 17, 2014 ... a Phase 2 study evaluating the investigational oral ... of patients with severe, chronic itch who are ... of care, including topical steroids and antihistamines. ... change in Visual Analog Scale (VAS) itch score ...
(Date:12/15/2014)... YORK , Dec. 15, 2014  GlassesOff Inc. ... Yuval Bar-Gil as an independent director of the ... founder of AeroScout and served as its CEO until ... in 2012, a $240 million transaction. Recognized as the ... Mr. Bar-Gil,s leadership, AeroScout provided Wi-Fi -based RFID solutions ...
(Date:12/13/2014)... Clarassance, a privately held clinical-stage biotechnology company ... Therabron Therapeutics , Inc. The new name is derived ... structure in the lungs similar to branches on a ... protein therapeutics for the treatment of respiratory diseases. ... name to mark the company's escalation into the clinical ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... Aug. 14 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc.,(TSX: DDD; OTCBB: DRUG; BBSE: ... 30, 2007. Highlights of the Second Quarter, 2007, - ... for the same period of 2006, ... quarter 2007;, - Gross profit and ...
... /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: YMI ... company that identifies,develops and commercializes differentiated products ... (Wedel, Germany), its European partner,for the development ... recruited the 40th and final patient in ...
... for Role in Engineering Microbes to Produce Lower ... Recipients to be Honored at Technology Review,s Emerging ... Technologies Conference ... is,pleased to announce that Neil Renninger, Ph.D., co-founder and senior ...
Cached Biology Technology:Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007 2Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007 3ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB 2ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB 3ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB 4Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Review's Prestigious TR35 List of Top Young Innovators 2Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Review's Prestigious TR35 List of Top Young Innovators 3
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
...
Mouse monoclonal antibody to UGT2B10 - UDP glucuronosyltransferase 2 family, polypeptide B10...
Biology Products: